The Gross Margin of Helix Biopharma Corp (HBP.TO) is 63.80%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-07-31 | 63.80% |